- This event has passed.
“Autoimmunity and Infection: The Group A Streptococcal Sequelae” (Hybrid Event)
Madeleine Cunningham, MD, PhD
George Lynn Cross Research Professor; Presbyterian Health Foundation Presidential Professor; Director, T32 Immunology Training Program
University of Oklahoma Health Sciences Center
Dr. Madeleine Cunningham is George Lynn Cross Research Professor of Microbiology and Immunology at the University of Oklahoma Health Sciences Center. She received her PhD at the University of Tennessee Center for the Health Sciences where she trained under Dr.s Gene Stollerman and Edwin Beachey. She was a postdoctoral fellow at the Oklahoma Medical Research Foundation in Oklahoma City USA before joining the faculty in the College of Medicine at the University of Oklahoma Health Sciences Center after being recruited by Dr Joseph Ferretti. Dr Cunningham studies group A streptococcal pathogenesis and immunity and has been supported by the National Heart Lung and Blood Institute (NHLBI) including a Career Development and Merit Award to investigate the pathogenesis of rheumatic heart disease, myocarditis and dilated cardiomyopathy. She has a strong focus on human translational research in autoimmunity, molecular mimicry, and Infection, including biomarkers of disease and outcomes. She developed human monoclonal antibody technology to unravel the autoimmune pathogenesis of human inflammatory diseases of the heart and brain including rheumatic fever and rheumatic heart disease. Her work has also been supported by the American Heart Association and the National Institute of Mental Health. She has been a consultant to the National Academy of Sciences and represented the United States in the US-Indo Vaccine Action Program in India to promote research on group A streptococcal vaccines.
Dr. Cunningham’s OBJECTIVES:
- Identify and define the group A streptococcal sequelae.
- Define the underlying autoimmune causes of the group A streptococcal sequelae.
- Define the diagnosis of the group A streptococcal sequelae.
Faculty Disclosures
Dr. Cunningham has indicated that she has the following relevant financial relationships with commercial interests:
- Owner: Moleculera Biosciences
Planning Committee Disclosure
Dr. Deshpande has indicated the following relevant financial relationships with commercial interests:
- Advisor – GI Health Foundation
Dr. Weiss has indicated the following relevant financial relationships with commercial interests:
- Advisor – Prizm LLC
- Advisor – Fortress Pharmaceuticals
Laura Pinzon has indicated she has no relevant financial relationships with commercial interests.
Target Audience
Primary care physicians.
Accreditation
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”